Experts Raise Concerns Over 'Careless Prescription' of SSRI Antidepressants

Selective Serotonin Reuptake Inhibitors (SSRIs), including widely recognized brands like Prozac and Zoloft, are cornerstone treatments in psychiatry and rank among the world's most commonly prescribed medications for mental health conditions. They are designed to increase the level of serotonin in the brain, a neurotransmitter associated with mood regulation, thereby alleviating symptoms of depression, anxiety disorders, and other related conditions.

For millions worldwide, SSRIs have proven to be life-changing, offering relief from debilitating symptoms and enabling them to lead more functional lives. Their introduction marked a significant advancement in mental health care, providing a less sedating and generally safer alternative to older classes of antidepressants.

However, a growing body of expert opinion suggests that SSRIs may sometimes be prescribed "carelessly" or without a thorough evaluation of alternative treatments. Concerns include the potential for overprescription, particularly in cases where milder forms of depression or anxiety might benefit equally, or more, from psychotherapy, lifestyle changes, or other non-pharmacological interventions. Additionally, questions are raised about their long-term efficacy for all patients and the management of withdrawal symptoms upon discontinuation, which can sometimes be severe.